Paula Franson, M.S. APRN

Paula Franson joined Immatics in November 2024 and is responsible for developing and executing the Medical Affairs strategy, ensuring alignment with global objectives and supporting the commercialization of our TCR-based product candidates.

With more than 20 years of experience in biotech/pharma, Paula brings her expertise in building teams, scalable growth and intelligent product launches. She has positively impacted the lives of patients with cancer through the launch of six new molecular entities and numerous label expansions, most recent, axicabtagene ciloleucel (Yescarta®), the first cell therapy to be approved by the FDA for adults with large B-cell lymphoma.

Paula Franson is an Advanced Oncology Certified Nurse who spent the first decade of her career working in various oncology positions in the community and academic settings. She earned her graduate degree from Governors State University and nursing degree from Trinity Christian College.